SCHEMBL28131027

SCHEMBL28131027

NS(=O)(=O)c1ccc(N(CCCCN2CCOCC2)C2CCCCC2)c([N+](=O)[O-])c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.48
NPSR1 Q6W5P4 2/20 0.48
KDM4E B2RXH2 2/20 0.44
RAB9A P51151 2/20 0.43
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.43
NPC1 O15118 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42
ALDH1A1 P00352 2/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA9 Q16790 3/20 0.41
KMT2A Q03164 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
POLB P06746 1/20 0.39
PKM P14618 1/20 0.39
CA12 O43570 1/20 0.39
CA7 P43166 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28131010 0.82 BCL2L1 (0.46) KDM4EHRH3ALDH1A1CA1CA2
SCHEMBL2697697 0.79 HTT (0.48) MAPTNPSR1KDM4ERAB9ALMNA
SCHEMBL28130998 0.77 MAPT (0.44) MAPTNPSR1KDM4ERAB9ALMNA
SCHEMBL28295037 0.72 MEN1 (0.54) MAPTNPSR1KDM4EHRH3ALDH1A1
SCHEMBL1958846 0.72 CA2 (0.42) MAPTNPSR1KDM4ELMNAHTT
SCHEMBL1699958 0.72 MAPT (0.72) MAPTNPSR1KDM4ERAB9ALMNA
SCHEMBL30468003 0.72 MAPT (0.72) MAPTNPSR1KDM4ERAB9ALMNA
SCHEMBL27671287 0.71 ALDH1A1 (0.53) MAPTNPSR1KDM4ERAB9ALMNA
SCHEMBL16037787 0.71 HTT (0.53) MAPTNPSR1KDM4ERAB9ALMNA
SCHEMBL1958639 0.71 CA2 (0.41) MAPTNPSR1KDM4ELMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106397418-A APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBVIE公司 2017-02-15 CN disclosed